# IRUBIS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/irubis

- Industry: Medical Devices & Equipment
- Headquarters: Munich, Germany
- Website: www.irubis.com
- Total disclosed funding: $2.7M
- Latest round: Seed (Oct 6, 2022)
- Investors on record: 4

## About

Established in 2017 and based in Munich, Germany, IRUBIS GmbH operates as a biotechnology research platform that develops mid-infrared spectroscopy for bioprocessing. In August 2024, IRUBIS GmbH raised an undisclosed amount of pre-series A funding led by new investor BioProcess360 Partners, with participation from another new investor RoBet KG. Returning investors High-Tech Gründerfonds, Verve Ventures, Ventura BioMed Investors, and individual investors also participated in the round.

IRUBIS offers Monipa, a measuring system that employs an infrared spectroscopy-based system for automatic real-time monitoring and control of crucial parameters such as aggregation studies, contaminant detection or monitoring of target proteins and excipients in bioprocess engineering, and aids process development and biopharmaceutical production.

The company will use the funding to support the development of the company's bioprocesses technology.

## Funding rounds

- Seed, Oct 6, 2022, $2.7M — High-Tech Gruenderfonds, European Innovation Council, Verve Ventures, Ventura BioMed Investors

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Seed
- Verve Ventures (https://capitalatlas.ai/funds/verve-ventures) — Seed
- Ventura BioMed Investors (https://capitalatlas.ai/funds/ventura-biomed-investors) — Seed